Spray Dried Dispersion
Home | Services & Solutions | Drug Product | Oral | Enabling Technology Platform | Spray Dried Dispersion
Spray dried dispersion (SDD) is a commonly used technology to increase the bioavailability of poorly water-soluble compounds. Our integrated API and drug product spray drying service with highly-experienced cross-functional teams can accelerate development with in-parallel activities, delivering a fast and cost-effective approach to develop your molecule from preclinical to commercial.
Our state-of-the-art equipment and facilities enable seamless spray drying development and manufacturing from lab scale (50 mg – 1 kg) through to clinical and commercial production stage (1-100+ kg). We use four types of spray dryers (PSD-1, PSD-2, PSD-3, and PSD-4) to process compounds.
With high demand from clients globally, we are continuously expanding our capacity.
Our SDD drug product platform supports various dosage forms including tablets, capsules, powder, and granules.
Our highly experienced spray drying team has screened thousands of molecules, produced over 600 clinical and commercial batches in 2022.
Spray drying capability from lab scale to production scale with successful commercial launch experience
Experienced with all SDD polymers and solvents
Polymers
- HPMC-AS
- HPMC
- HPMC-P
- HPC
- PVP VA64
- PVP
- Eudragit L100-55
- Eudragit EPO
- PEG
- Soluplus
Solvents
- Ethanol
- Tetrahydrofuran
- Methanol
- Acetone
- Methylene Chloride
Selected Past Projects:
- Successful scale-up from PSD-1 to PSD-3, completed in 3 months and delivered 1,400 kg SDD intermediate for phase III clinical trials
- Overcome slow dissolution of micronized crystal with high melting point (4-fold boost in exposure)
- Pediatric sachets from formulation optimization to clinical manufacturing within 6 months
